76 related articles for article (PubMed ID: 21549780)
1. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
[TBL] [Abstract][Full Text] [Related]
2. Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry.
Wang J; Yang J; Ge J; Hua R; Liu R; Li X; Wang X; Shao Y; Sun E; Wu D; Qin C; Wen Z; Bu Z
Virol J; 2016 Jun; 13():109. PubMed ID: 27342050
[TBL] [Abstract][Full Text] [Related]
3. West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.
Khatibzadeh SM; Gold CB; Keggan AE; Perkins GA; Glaser AL; Dubovi EJ; Wagner B
Am J Vet Res; 2015 Jan; 76(1):92-100. PubMed ID: 25535666
[TBL] [Abstract][Full Text] [Related]
4. Lessons Learned from West Nile Virus Infection:Vaccinations in Equines and Their Implications for One Health Approaches.
Naveed A; Eertink LG; Wang D; Li F
Viruses; 2024 May; 16(5):. PubMed ID: 38793662
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and risk factors for infection with West Nile virus in Saskatchewan horses, 2003.
Epp T; Waldner C; Leighton FA; Berke O; Townsend HG
Can J Vet Res; 2007 Oct; 71(4):256-63. PubMed ID: 17955899
[TBL] [Abstract][Full Text] [Related]
6. Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.
Zlatkovic J; Stiasny K; Heinz FX
J Virol; 2011 Mar; 85(5):1994-2003. PubMed ID: 21147919
[TBL] [Abstract][Full Text] [Related]
7. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.
Davis BS; Chang GJ; Cropp B; Roehrig JT; Martin DA; Mitchell CJ; Bowen R; Bunning ML
J Virol; 2001 May; 75(9):4040-7. PubMed ID: 11287553
[TBL] [Abstract][Full Text] [Related]
8. Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.
Dayan GH; Pugachev K; Bevilacqua J; Lang J; Monath TP
Viruses; 2013 Dec; 5(12):3048-70. PubMed ID: 24351795
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.
Tinker JK; Yan J; Knippel RJ; Panayiotou P; Cornell KA
Toxins (Basel); 2014 Apr; 6(4):1397-418. PubMed ID: 24759174
[TBL] [Abstract][Full Text] [Related]
10. Plant-made vaccines against West Nile virus are potent, safe, and economically feasible.
Chen Q
Biotechnol J; 2015 May; 10(5):671-80. PubMed ID: 25676782
[TBL] [Abstract][Full Text] [Related]
11. Full-Genome Sequence of a Neuroinvasive West Nile Virus Lineage 2 Strain from a Fatal Horse Infection in South Africa.
Mentoor JL; Lubisi AB; Gerdes T; Human S; Williams JH; Venter M
Genome Announc; 2016 Jul; 4(4):. PubMed ID: 27469963
[TBL] [Abstract][Full Text] [Related]
12. Horses as Sentinels for the Circulation of Flaviviruses in Eastern-Central Germany.
Gothe LMR; Ganzenberg S; Ziegler U; Obiegala A; Lohmann KL; Sieg M; Vahlenkamp TW; Groschup MH; Hörügel U; Pfeffer M
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243194
[TBL] [Abstract][Full Text] [Related]
13. Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development.
Wu B; Qi Z; Qian X
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112794
[TBL] [Abstract][Full Text] [Related]
14. European College of Equine Internal Medicine consensus statement on equine flaviviridae infections in Europe.
Cavalleri JV; Korbacska-Kutasi O; Leblond A; Paillot R; Pusterla N; Steinmann E; Tomlinson J
J Vet Intern Med; 2022 Nov; 36(6):1858-1871. PubMed ID: 36367340
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence and Risk Factors for Equine West Nile Virus Infections in Eastern Germany, 2020.
Ganzenberg S; Sieg M; Ziegler U; Pfeffer M; Vahlenkamp TW; Hörügel U; Groschup MH; Lohmann KL
Viruses; 2022 May; 14(6):. PubMed ID: 35746662
[TBL] [Abstract][Full Text] [Related]
16. Equids' Core Vaccines Guidelines in North America: Considerations and Prospective.
Desanti-Consoli H; Bouillon J; Chapuis RJJ
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335029
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiological Survey of West Nile Virus Infections in Horses from Berlin/Brandenburg and North Rhine-Westphalia, Germany.
Bergmann F; Trachsel DS; Stoeckle SD; Bernis Sierra J; Lübke S; Groschup MH; Gehlen H; Ziegler U
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215837
[TBL] [Abstract][Full Text] [Related]
18. Integrating Spatiotemporal Epidemiology, Eco-Phylogenetics, and Distributional Ecology to Assess West Nile Disease Risk in Horses.
Humphreys JM; Pelzel-McCluskey AM; Cohnstaedt LW; McGregor BL; Hanley KA; Hudson AR; Young KI; Peck D; Rodriguez LL; Peters DPC
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578392
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity and virulence of West Nile virus revisited eight decades after its first isolation.
Saiz JC; Martín-Acebes MA; Blázquez AB; Escribano-Romero E; Poderoso T; Jiménez de Oya N
Virulence; 2021 Dec; 12(1):1145-1173. PubMed ID: 33843445
[TBL] [Abstract][Full Text] [Related]
20. Animal and Human Vaccines against West Nile Virus.
Saiz JC
Pathogens; 2020 Dec; 9(12):. PubMed ID: 33371384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
